These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4627219)

  • 1. L-dopa, behavioral activation and psychopathology.
    Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():472-93. PubMed ID: 4627219
    [No Abstract]   [Full Text] [Related]  

  • 2. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of l-dopa in man.
    Goodwin FK
    Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical aspects of human behavior].
    Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Wien Z Nervenheilkd Grenzgeb; 1973; 31(3):191-215. PubMed ID: 4360134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
    Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
    Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
    Morselli PL; Rizzo M; Tognoni G
    Recenti Prog Med; 1970 Feb; 48(2):97-124. PubMed ID: 5467589
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychiatric side effects of levodopa in man.
    Goodwin FK
    JAMA; 1971 Dec; 218(13):1915-20. PubMed ID: 5000569
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
    Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
    Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa metabolism in man (with special reference to parkinsonism).
    Sandler M
    Sci Basis Med Annu Rev; 1972; ():161-73. PubMed ID: 4564341
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.
    Muenter MD; Tyce GM
    Mayo Clin Proc; 1971 Apr; 46(4):231-9. PubMed ID: 5573818
    [No Abstract]   [Full Text] [Related]  

  • 13. Mental effects of L-dopa.
    Murphy DL
    Annu Rev Med; 1973; 24():209-16. PubMed ID: 4575853
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral catecholamines after levodopa therapy.
    Greer M; Collins GH; Anton AH
    Arch Neurol; 1971 Nov; 25(5):461-7. PubMed ID: 5110888
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa: alterations in behavior.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):383-96. PubMed ID: 4930867
    [No Abstract]   [Full Text] [Related]  

  • 16. An L-dopa paradox: bipolar behavioral alterations.
    Riklan M
    J Am Geriatr Soc; 1972 Dec; 20(12):572-5. PubMed ID: 4639420
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled study of the effect of L-dopa upon selected cognitive and behavioral functions.
    Boshes B; Arbit J
    Trans Am Neurol Assoc; 1970; 95():59-63. PubMed ID: 4936414
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain dopamine and noradrenaline in 3 Parkinsonians deceased during L-dopa treatment.
    Buscaino GA; Jori A; Campanella G
    Acta Neurol (Napoli); 1972; 27(6):537-44. PubMed ID: 4651485
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
    Fischer PA
    Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-tryptophan therapy of DOPA psychoses].
    Birkmayer W; Neumayer E
    Nervenarzt; 1972 Feb; 43(2):76-8. PubMed ID: 4501978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.